SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-23-007555
Filing Date
2023-10-11
Accepted
2023-10-11 10:02:35
Documents
14
Period of Report
2023-10-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bglc_8k.htm   iXBRL 8-K 23719
  Complete submission text file 0001477932-23-007555.txt   153164

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bglc-20231004.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bglc-20231004_lab.xml EX-101.LAB 15716
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bglc-20231004_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bglc-20231004_pre.xml EX-101.PRE 9984
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bglc-20231004_def.xml EX-101.DEF 2099
8 EXTRACTED XBRL INSTANCE DOCUMENT bglc_8k_htm.xml XML 3868
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 60122126512
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

IRS No.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41750 | Film No.: 231319715
SIC: 8071 Services-Medical Laboratories